Discover and read the best of Twitter Threads about #DAPT
Most recents (16)
Follow this #CardioTwitter #Thread
to get an overview of ALL
🚨#ESCcongress #HotLineSessions🚨
Including:
➡️14 #OnePager #CongressCards
➡️Links to on-demand stream
➡️Jorunal weblinks
➡️Hashtag of the author/presenter
PART 1 ⬇️
to get an overview of ALL
🚨#ESCcongress #HotLineSessions🚨
Including:
➡️14 #OnePager #CongressCards
➡️Links to on-demand stream
➡️Jorunal weblinks
➡️Hashtag of the author/presenter
PART 1 ⬇️
1.1./ #TIME trial - The Treatment in Morning versus Evening study.
📕🔗:: NOT YET PUBLISHED
On-demand ESC 📺: bit.ly/3AQuvkB
#ESCcongress
📕🔗:: NOT YET PUBLISHED
On-demand ESC 📺: bit.ly/3AQuvkB
#ESCcongress
1) Welcome to a new #accredited #tweetorial on parenteral #antiplatelet therapy in #neurovascular interventions. Our expert author is Fawaz Al-Mufti MD @almuftifawaz, interventional #neurologist Interventional Neurologist @NYMedcollege @WestchesterMed @neurocritical @svinsociety
2) This program is intended for #healthcare providers & is accredited for 0.5h CE/#CME for #physicians #PhysicianAssociate #nursepractitioner #nurse #pharmacists and is supported by educational grants from AstraZeneca, Bayer, and Chiesi.
3) Be sure to see prior tweetorials on #antiplatelet management, still available for credit, at cardiometabolic-ce.com/category/plate…. Faculty disclosures are listed at cardiometabolic-ce.com/disclosures/.
Don’t miss a new accredited #tweetorial launching TOMORROW here on @cardiomet_CE. #Interventional #cardiologist, #researcher, & #SoMe education leader @DLBHATTMD will be talking all about #aspirin, its role in #cardiovascular wellness & prevention, and new approaches to . . .
. . . formulation and dosing. Don't miss it--FOLLOW US NOW! @cpcannon @AnnMarieNavar @DrM_ODonoghue @DrMarthaGulati @practicalcardio @GuyattGH @DrMauricioCohen @SVRaoMD @ASPCardio @PlateletDoc @stephanamayer @CMichaelGibson @JJheart_doc @DrSheilaSahni @mmamas1973 @Drroxmehran
1) Welcome to an #accredited #tweetorial on the foundational role of #aspirin in #cardiovascular care. There are new approaches to #aspirin formulation & dosing. This program is accredited for 0.50h CE/#CME. I am @DLBHATTMD. #FOAMed #cardiotwitter #medtwitter
Watch here TOMORROW for a new accredited, #tweetorial by neurointensivist @stephanamayer on optimizing DAPT and other interventions for secondary stroke prevention after #AIS or #TIA. Earn 0.5 CE/#CME credits: #physicians, #nurses, #pharmacists! #NoMercyOnStroke @svinsociety
@WorldStrokeCampaign @American_Stroke @WorldStrokeOrg @neurocriticalcare
@MainaliShradda @vcurrutiaMD @almuftifawaz @drdangayach @AlexChebl @GhadaMohamedMD @AmeerEHassan @aartisarwal @sheth_kevin @MitchElkind #medtwitter @academiccme #neurotwitter #FOAMed #FOAM #stroketwitter
@MainaliShradda @vcurrutiaMD @almuftifawaz @drdangayach @AlexChebl @GhadaMohamedMD @AmeerEHassan @aartisarwal @sheth_kevin @MitchElkind #medtwitter @academiccme #neurotwitter #FOAMed #FOAM #stroketwitter
1) Welcome to a #tweetorial on how to optimize therapy for secondary #stroke prevention. Accredited for 0.50 credits! I am your host @stephanamayer. Be sure to see prior tweetorials in the broader cardiometabolic space and earn more CE/#CME credit at cardiometabolic-ce.com
1/24 This month’s #EHJCaseReports #tweetorial focuses on percutaneous left atrial appendage occlusion.
Is #LAAO the exact solution for preventing stroke & embolism in #AF pts who can’t tolerate #OAC?
Or, a new problem while seeking a solution?
doi.org/10.1093/ehjcr/…
#CardioEd
Is #LAAO the exact solution for preventing stroke & embolism in #AF pts who can’t tolerate #OAC?
Or, a new problem while seeking a solution?
doi.org/10.1093/ehjcr/…
#CardioEd
2/24
🎯 The rationale of #LAAO
🔸 In non-valvular #AF patients, 90% of thrombus is located in the #LAA
🔸 These thrombi embolise to the 🧠 & cause #stroke
🎯 Don't miss the ‘#EHRA_ESC #EAPCI expert consensus document on catheter-based #LAAO –an update’ doi.org/10.1093/europa…
🎯 The rationale of #LAAO
🔸 In non-valvular #AF patients, 90% of thrombus is located in the #LAA
🔸 These thrombi embolise to the 🧠 & cause #stroke
🎯 Don't miss the ‘#EHRA_ESC #EAPCI expert consensus document on catheter-based #LAAO –an update’ doi.org/10.1093/europa…
3/24
#LAA closure devices should be safe, efficent and easy to deploy.
📌 Currently available catheter-based devices for #LAAO have different principles.
A- Plug ➡️ Watchman
B- Pacifier ➡️ Amplatzer Amulet
C- Ligation ➡️ Lariat
doi.org/10.1093/europa…
#LAA closure devices should be safe, efficent and easy to deploy.
📌 Currently available catheter-based devices for #LAAO have different principles.
A- Plug ➡️ Watchman
B- Pacifier ➡️ Amplatzer Amulet
C- Ligation ➡️ Lariat
doi.org/10.1093/europa…
🔻🔻Live in a few minutes ⌛️
#ClinicalTrialsMasterclass
🫀Designing trials in antiplatelet therapy, with @Drroxmehran @DjawidHashemi @aayshacader
🔗
@KardiologieHH @ANazmiCalik @mirvatalasnag @Hragy @mmamas1973 @vass_vassiliou #CardioTwitter #DAPT
#ClinicalTrialsMasterclass
🫀Designing trials in antiplatelet therapy, with @Drroxmehran @DjawidHashemi @aayshacader
🔗
@KardiologieHH @ANazmiCalik @mirvatalasnag @Hragy @mmamas1973 @vass_vassiliou #CardioTwitter #DAPT
Don’t miss a new accredited #tweetorial launching TOMORROW here on @cardiomet_CE. #Cardiologist, #SoMe education advocate, and true #Renaissance man @CMichaelGibson will be discussing a novel #aspirin prep that has PK/PD like plain #ASA . . .
. . . but a different site of absorption--with greater predictability than ECASA. DON'T MISS IT!! @DLBHATTMD @cpcannon @AnnMarieNavar @DrM_ODonoghue @DrMarthaGulati @practicalcardio @GuyattGH @DrMauricioCohen @SVRaoMD @ASPCardio @PlateletDoc @stephanamayer #FOAMed #CardioTwitter
1) Welcome to a #tweetorial where we’ll explore how changing the formulation of #aspirin & where it's absorbed in the GI tract can ⬇️the risk of acute GI injury, but still maintain predictable absorption. This program is accredited for 0.50h CE/#CME. I am @CMichaelGibson. #FOAMed
Don’t miss a new accredited #tweetorial launching Monday here on @cardiomet_CE. Our newest core faculty member, #interventionalist & #SoMe education enthusiast @aayshacader will be discussing #antiplatelet tx in an oh-so-tough scenario--#cardiogenicshock complicating #STEMI.
FOLLOW US now and be there! @DLBHATTMD @DrMauricioCohen @SVRaoMD @HeartBobH @HeartOTXHeartMD @Heart_SCCT @TCTMD @GreggWStone @gabrielsteg @cpcannon @agtruesdell @evandrofilhobr @SCAI @SripalBangalore @mmamas1973 @SABOURETCardio @PCRonline @Pooh_Velagapudi #CardioTwitter
1) Welcome to a tweetorial on antiplatelet therapy for #STEMI in #cardiogenic shock #CS! Accredited for 0.50 credits by @academiccme! I am @aayshacader. Be sure to see prior tweetorials on this topic and still earn credit at cardiometabolic-ce.com/category/plate…
#WeekendLecture
Intracranial Atherosclerotic Disease #ICAD
#ICAD leads to changes ranging from minor wall thickening to #hemodynamically significant luminal stenosis and is one of the most #common causes of #stroke worldwide
ahajournals.org/doi/10.1161/CI…
🧵
Intracranial Atherosclerotic Disease #ICAD
#ICAD leads to changes ranging from minor wall thickening to #hemodynamically significant luminal stenosis and is one of the most #common causes of #stroke worldwide
ahajournals.org/doi/10.1161/CI…
🧵
#WeekendLecture
#ICAD
✅10% of stroke, based on autopsy studies
bit.ly/3v6Lhrd
✅More prevalent in #African Americans, #Hispanics, and #Asians as compared with whites
bit.ly/3AuSiDt
Other risk factors in table
#ICAD
✅10% of stroke, based on autopsy studies
bit.ly/3v6Lhrd
✅More prevalent in #African Americans, #Hispanics, and #Asians as compared with whites
bit.ly/3AuSiDt
Other risk factors in table
#WeekendLecture
#ICAD
In postmortem studies
👉degree of luminal #stenosis
👉% of the plaques containing >40% #lipid area
👉prevalence of intraplaque #hemorrhage, #neovasculature and #thrombus,
were higher in those #plaques associated with #infarct
🔹karger.com/Article/Abstra…
#ICAD
In postmortem studies
👉degree of luminal #stenosis
👉% of the plaques containing >40% #lipid area
👉prevalence of intraplaque #hemorrhage, #neovasculature and #thrombus,
were higher in those #plaques associated with #infarct
🔹karger.com/Article/Abstra…
Don't miss the launch Monday of a new accredited tweetorial on optimizing duration of antiplatelet therapy after #ACS/#PCI, with expert author @mirvatalasnag leading us through the data. #ACCWIC @DrMarthaGulati @ShelleyZieroth @TYWangMD @Drroxmehran @aayshacader #cardiotwitter
Watch here tomorrow a new accredited, serialized tweetorial on optimizing duration of antiplatelet therapy after ACS/PCI. Earn 0.5 CE/#CME credits: #physicians, #nurses, #pharmacists! Expert faculty @mirvatalasnag. #medtwitter @academiccme #cardiotwitter #FOAMed @CardioNerds
1) Welcome to a tweetorial on optimizing duration of antiplatelet tx after #ACS/#PCI! Accredited for 0.50 credits by @academiccme! I am @mirvatalasnag . Be sure to see prior tweetorials on this topic and still earn credit at cardiometabolic-ce.com/category/plate…
#CMGsays: Join here tomorrow for the launch of a new accredited tweetorial on optimal management of diabetic and other high-risk patients with stable CAD, particularly those with previous PCI, to reduce the risk of MI or stroke. Expert faculty is the incomparable @CMichaelGibson
Earn 0.5 CE/CME credits: #physicians, #nurses, #pharmacists! #medtwitter @academiccme #CardioTwitter @MedTweetorials @CardioNerds @SABOURETCardio @DLBHATTMD @gabrielsteg @DrMauricioCohen @cpcannon @DocSavageTJU @djc795 @DFCapodanno @SnayCardsPharmD @beaverspharmd
And you’ll learn how these data should impact your practice:
Join here tomorrow for the launch of a new accredited tweetorial on DAPT in patients with stable CAD+diabetes who have not (yet!) had an MI or stroke! Earn 0.5 CE/CME credits: physicians, nurses, pharmacists! Expert faculty @gabrielsteg. #medtwitter @academiccme #CardioTwitter
1) Welcome to a #tweetorial on #DAPT in patients with stable CAD+#diabetes who have not had an MI or stroke. Accredited for 0.5h by @academiccme: #physicians, #nurses, #pharmacists! I am @gabrielsteg . . .
. . . This educational activity is intended for healthcare providers and is supported by grants from Abbott, AstraZeneca, Bayer, Chiesi, and NovoNordisk.
While #EuroPCR is in full swing, here is a special #ACC21 #tweetorial brought to you by @ANazmiCalik focusing on what you need to remember about the results of the main #interventionalcardiology trials 📈📉📊 released at the conference! #CardioTwitter
⤵️⤵️
⤵️⤵️
1/9 #ACC21 #Tweetorial @ANazmiCalik
#ADAPTABLE: Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness
Take 🏠:
-if the patient isn't on Aspirin, START w/ 81mg
-if the patient is on 81 mg Aspirin, STAY
-if the patient is on 325mg, MAY STAY
#ADAPTABLE: Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness
Take 🏠:
-if the patient isn't on Aspirin, START w/ 81mg
-if the patient is on 81 mg Aspirin, STAY
-if the patient is on 325mg, MAY STAY
2/9 #ACC21 #Tweetorial @ANazmiCalik
#LAAOS III: Left Atrial Appendage Occlusion Study III
Take home 🏠 message:
Among patients with AF undergoing cardiac surgery, surgical LAA occlusion reduces ischemic stroke by 33%, compared to no occlusion.
#LAAOS III: Left Atrial Appendage Occlusion Study III
Take home 🏠 message:
Among patients with AF undergoing cardiac surgery, surgical LAA occlusion reduces ischemic stroke by 33%, compared to no occlusion.
Watch here tomorrow for the launch of a new accredited tweetorial on use of P2Y12 inhibitor monotherapy after PCI! Earn 0.5 CE/CME credits: physicians, nurses, pharmacists! Expert faculty @SVRaoMD. #medtwitter @academiccme #cardiotwitter
1) Welcome to a tweetorial on the use of P2Y12 inhibitor monotherapy after PCI! Accredited for 0.50 credits by @academiccme: physicians, nurses, pharmacists! I am @SVRaoMD.
2) This series is supported by educational grant funding from Abbott, AstraZeneca, Bayer, Chiesi, and NovoNordisk. Follow this thread for credit. And here is a case …
‘Overall, #antiplatelet monotherapy is ineffective for #stroke prevention [for #AtrialFibrillation] & potentially harmful (especially #elderly), whereas #DAPT associated with bleeding risk similar to OAC. Hence, antiplatelets should not be used for #stroke prevention in #AF’
2020 ESC Guidelines for the diagnosis and management of #AtrialFibrillation #ESCCongress : academic.oup.com/eurheartj/adva…
‘Between 2009 & 2018, in #England, the use of #OAC for #stroke prophylaxis in #AtrialFibrillation increased, with #DOAC accounting for over half of OAC uptake in 2018.’
1/2 Our most recent paper w @Simoneccles66 funded by @NorfHeartTrust led by @NIHRresearch academic fellow Natasha Corballis & @upulwick from @UeaMed @NNUH on drug coated balloons for PCI & safety of ONE MONTH #DAPT 4 DE NOVO coronaries onlinelibrary.wiley.com/doi/full/10.10… @mirvatalasnag
2/2 in the paper ⬆️ we show that one month DAPT following DCB is safe for de novo coronaries of any size- bringing into question the recent guidance from ESC for 6 months DAPT following DCB onlinelibrary.wiley.com/doi/full/10.10… @AnastasiaSMihai @ShrillaB @ajaykirtane @claireraph @VijayKunadian
@threadreaderapp compile
